Transfection Technologies Market Size, Segmentation, Application Analysis, Trends, & forecast by 2030

Transfection Technologies Market Size, Segmentation, Application Analysis, Trends, & forecast by 2030

Published Nov 22 


Hemant Borikar
By Hemant Borikar

9 Articles


Global Transfection Technologies Market is expected to undergo a CAGR of 8.1% during the forecast

period 2023 to 2030. This market was USD 1073.22 million in 2022, would rocket up to USD 2001.22 million by 2030.

Global Transfection Technologies Market, By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection), Product (Reagent, Instrument, Others), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Protein Production, Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End-user (Pharmaceutical and biotechnology companies, Contract research organizations, Academic and research institutes) – Industry Trends and Forecast to 2030.

Data Bridge Market Research analyses that the transfection technologies market which was USD 1073.22 million in 2022, is expected to reach USD 2001.22 million by 2030, at a CAGR of 8.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Transfection Technologies Market Regional Analysis/Insights

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transfection technologies market because of an increase in the number of cases of infectious diseases requiring antibiotics and an increase in the use of cell-based products requiring transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases in this region.

Transfection Technologies Market Segmentation

Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection), Product (Reagent, Instrument, Others), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Protein Production, Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection).

Request Access for Transfection Technologies Market Sample Report:

Transfection Technologies Market Country Level Analysis

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transfection technologies market because of an increase in the number of cases of infectious diseases requiring antibiotics and an increase in the use of cell-based products requiring transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases in this region.

Transfection Technologies Market Share Analysis

The transfection technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection technologies market.

Some of the major players operating in the transfection technologies market are:

Lonza (Switzerland)

Promega Corporation (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

Roche Molecular Systems, Inc. (U.S.)

QIAGEN (Germany)

Inovio Pharmaceuticals (U.S.)

Polyplus Transfection (France)

Mirus Bio LLC (U.S.)

Takara Bio Inc. (Japan)

SignaGen Laboratories (U.S.)

MaxCyte, Inc. (U.S.)

Genlantis Inc. (U.S.)

Techulon (U.S.)

BioAstrum Corporation (U.S.)

Altogen Biosystems (U.S.)

OZ Biosciences (France)

Boca Scientific, Inc. (U.S.)

Biontex Laboratories GmbH (Germany)

Access Full Report:-

Major TOC of the Digital Out of Home Advertising Report

Chapter One:

Chapter Two:

Get TOC of the Report:

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com


Human Resources News

Advertisement